The decreasing rates of V_p with temperature. by Nazlı Tunar Özcan (14833635)

Subjects:

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Percentage of <i>Ae. aegypti</i> and <i>Ae. albopictus</i> trapped in each pagoda (pagodas are ordered by a decreasing percentage of <i>Ae. aegypti</i>). by Vincent Herbreteau (119307)

“…<p>Percentage of <i>Ae. aegypti</i> and <i>Ae. albopictus</i> trapped in each pagoda (pagodas are ordered by a decreasing percentage of <i>Ae. aegypti</i>).…”

The distributions of the end-simulation adolescence-limited proportion when (a) <i>k</i> is increased or decreased by 50%, (b) <i>c</i> is increased or decreased by 50%, (c) <i>γ</i> is increased or decreased by 50%, and (d) Δ<i>e</i> is increased or decreased by 50%, compared against the benchmark distribution <i>F</i>(<b>p</b>₀) for the parameters shown in Table 1. by Jia Ning Leaw (752775)

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)

NFκB-p50 knockdown decreases CD44 expression. by Shannon M. Smith (115335)

Damsin (D) and ambrosin (A) treatment decreases the CSC population. by Wendy Soria Sotillo (4408105)

Prevalence and anatomic level of stenosis ≥ 50% in either limb. by O. Stivalet (6890189)

EC50 and percentage decrease in intracellular <i>Listeria</i> viability for effective compounds. by Marie-Eve Charbonneau (5658799)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

DMB treatment decreased neuronal apoptosis in cerebral ischemia. by Huinan Zhang (849524)

Silencing of <i>Aacasps16</i> led to decreased apoptosis induced by UV and Act D treatment. by Kun Meng (141278)

Reduction of the <i>Ae</i>. <i>aegypti</i> population following ATSB treatment at 'sugar poor' and 'sugar rich' sites as indicated by the decrease in landings of females on human volunteers compared to their frequency at untreated control sites. by Fatoumata Sissoko (6848270)

“…<p>Reduction of the <i>Ae</i>. <i>aegypti</i> population following ATSB treatment at 'sugar poor' and 'sugar rich' sites as indicated by the decrease in landings of females on human volunteers compared to their frequency at untreated control sites.…”

Affinity analysis results (with a confidence level above 50%). by Marta R. Jabłońska (8491404)

Topography of the relationship between the change in alpha power decrease and the change in M50 gating ratio. by Tzvetan Popov (315385)

“…B: Relationship between change in alpha power decrease (abscissa, negative values indicate improvement) and pre-to-post-training change in M50 gating ratio (ordinate, positive values indicate changes towards normal, that is, smaller gating ratio) by patient training group based on the ROI in 4A.…”

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

SDG decreases iron-induced apoptosis in H9c2 cells. by Stephanie Puukila (568109)

KOR-agonist (U50'488) and MOR-agonist (DAMGO) decrease symptoms in OVA-allergic mice. by Swantje C. Duncker (154707)

Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

“…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”